Detection of Circulating Biomarkers of Immunogenic Cell Death

NCT02921854 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Maastricht Radiation Oncology

Collaborators